Updates

Kalibrate

April 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

No surprises in the good looking maiden H1 results from Kalibrate; even the move to report in dollars had been flagged by us last month. As it was, sales for H1 were US$14.1m, up 18%. EBITDA was $1.96m up 55%. North America delivered a particularly strong performance (+53% year-on-year) as did Planning sales in Japan and South-East Asia. Recurring revenues have grown to US$18.8m at the end of December, up US$3m on six months earlier. Keep on buy list. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Pressure Technologies - Eps enhancing acquisition of Roota

EKF Diagnostics - Three acquisitions in a month

Kalibrate (July 2017)

Kalibrate (October 2015)

Kalibrate (April 2015)

Kalibrate (October 2014)

Kalibrate - Shares on cusp of breakout (September 2014)

Kalibrate - Comfortably ahead of market forecasts (July 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X